This Special Communication describes factors surrounding rising rates of early-onset cancer in the US. from JAMA Internal Medicine Online First https://ift.tt/W1HmA7D

This Viewpoint discusses the benefits of and strategies for integrating postpartum screenings into newborn visits. from JAMA Health Forum New Online https://ift.tt/YsbPu7C

This JAMA Forum discusses the importance of scientific evidence to support health policy in the context of the recent passage of the One Big Beautiful Bill Act and its cuts to Medicaid. from JAMA Health Forum New Online https://ift.tt/FKh37Hl

To the Editor We read with interest the recent article by Daw et al, “Trends and Disparities in Maternal Self-Reported Mental and Physical Health.” This study addresses an important and timely topic—maternal mental health—using data from the Health Resources and Services Administration’s National Survey of Children’s Health (NSCH). As data stewards, we are concerned that the analyses and framing of the study’s findings overstate their generalizability to the population of US mothers and overlooks declines in mental health among other caregivers. from JAMA Internal Medicine Online First https://ift.tt/l7uhbrL

In Reply In 2024, an advisory from the US Surgeon General identified parental mental health as a pressing public health issue, highlighting rising levels of parental stress. Following this advisory, our study used the National Survey of Children’s Health (NSCH) to investigate recent trends and disparities in self-reported maternal health and found substantial declines in mental health. Between 2016 and 2023, the adjusted prevalence of fair/poor mental health increased 3.5 percentage points (pp; increase of 64.0% from a baseline of 5.5%). This mental health decline was largely consistent across socioeconomic subgroups. We thank Lebrun-Harris et al for their thoughtful comments on our study and their important work as data stewards. In their Letter, they raised 3 concerns regarding the generalizability and framing of our results. from JAMA Internal Medicine Online First https://ift.tt/HO0qs2L

This systematic review and meta-analysis evaluates the efficacy and acceptability of cognitive behavioral therapy for insomnia in individuals with chronic disease. from JAMA Internal Medicine Online First https://ift.tt/4kLiHgx

This Review explores the factors that predispose Hispanic/Latino patients to metabolic dysfunction–associated steatotic liver disease and metabolic dysfunction–associated steatohepatitis and discusses the screening, identification, and management of at-risk patients. from JAMA Internal Medicine Online First https://ift.tt/h0OduZJ

This Viewpoint summarizes the progress of 5 US states in their efforts to invest in primary care, focusing on key similarities and differences to help inform ongoing policy discussions in other states. from JAMA Health Forum New Online https://ift.tt/i80YZPc

This JAMA Forum discusses congressional actions that have been taken to try to deter state regulation of artificial intelligence (AI), provides examples of AI regulation initiatives by the states, and provides states with areas of focus for new AI regulations to ensure patient safety. from JAMA Health Forum New Online https://ift.tt/N7Bcb2H

To the Editor The recent article by Smith-Bindman et al projects that computed tomography (CT) imaging in 2023 may account for up to 5% of all future cancer diagnoses in the US based on the linear no-threshold model of radiation risk. While technically rigorous, the study relies on an extrapolative framework that remains deeply contested in radiation biology and toxicology. The linear no-threshold model presumes that any dose of ionizing radiation, however small, proportionally increases cancer risk, a claim that lacks empirical validation at diagnostic dose levels and ignores evidence of dose thresholds and biological repair mechanisms. from JAMA Internal Medicine Online First https://ift.tt/1AMwhEt

In Reply We thank Hsu et al for their Letter and agree that CT imaging advancements can reduce radiation doses; however, we disagree that we overestimated the doses in our study. Hsu et al suggest our estimates predate widespread deep learning reconstruction algorithm use and AI-driven protocol optimization, claiming these are now standard. Though not without dose reduction potential, their widespread adoption or measurable impact has not been established. The Letter’s references, including Koetzier et al, discuss development, limited availability, and potential, rather than implementation, concluding these techniques need thorough assessment before replacing conventional ones. While promising, photon-counting CT lacks clinical evidence of practical dose reductions. from JAMA Internal Medicine Online First https://ift.tt/xHPU5pw

This randomized clinical trial assesses the effectiveness of mobile integrated health compared with a transitions of care coordinator alone for improved health status and reduced readmissions among patients discharged after heart failure. from JAMA Internal Medicine Online First https://ift.tt/wEp2GJI

This secondary analysis of 2 randomized clinical trials assesses risk of cardiovascular disease due to hormone therapy in postmenopausal women with vasomotor symptoms. from JAMA Internal Medicine Online First https://ift.tt/fRw9YbN

This mixed-methods study identifies determinants of implementing fertility preservation benefit mandates in fertility and oncology clinics. from JAMA Health Forum New Online https://ift.tt/FdAThKV

This Viewpoint considers strategies for reducing Medicaid coverage disruptions for dual-eligible individuals. from JAMA Health Forum New Online https://ift.tt/IfphvGC

This JAMA Forum discusses the ramifications of the Republican tax and spending law and presents storylines that may be used in the next season of the television show The Pitt to illustrate these health care cuts and other related actions by the Trump administration. from JAMA Health Forum New Online https://ift.tt/8upjtvK

This cohort study compares the length of stay between patients covered by traditional Medicare and Medicare Advantage in the aftermath of the COVID-19 pandemic. from JAMA Internal Medicine Online First https://ift.tt/vQlAJyC

This randomized clinical trial examines 52-week efficacy and safety of elinzanetant in treating moderate to severe vasomotor symptoms that are associated with menopause. from JAMA Internal Medicine Online First https://ift.tt/CD8OGN6

This essay describes the author’s experience with a mountaineering injury and how this immobility, frustration, and loss of autonomy provided a glimpse into patients’ persistent pain, fear, and grief that accompany a permanent loss of function or life. from JAMA Internal Medicine Online First https://ift.tt/9a1lBEw

This Viewpoint evaluates Medicare reimbursement for custodial care support. from JAMA Internal Medicine Online First https://ift.tt/UzN04ST

Health Policy from JAMA Health Forum New Online https://ift.tt/qzisfTd

This Viewpoint discusses the importance of continuing community water fluoridation in the US. from JAMA Health Forum New Online https://ift.tt/tdpbjkK

This JAMA Forum discusses changes in enrollment across the individual states after unwinding of the Medicaid continuous coverage provision and the new enrollment barriers imposed after the passage of the One Big Beautiful Bill Act. from JAMA Health Forum New Online https://ift.tt/FgNyYXP

This Viewpoint proposes reform of the medical parole system, suggesting compassionate release applications of terminally ill incarcerated individuals be reviewed by an external medical board. from JAMA Internal Medicine Online First https://ift.tt/WDoMGNh